Are we really tackling the "evidence-based medicine issue" in Alzheimer's disease?

Affiliations

¹ Department of Neurology and Psychiatry, "Sapienza" University of Rome, Italy. Electronic address: marco.canevelli@gmail.com.
² Department of Neurology and Psychiatry, "Sapienza" University of Rome, Italy.
³ Epidemiology Center, National Institute of Health, Rome, Italy.
⁴ INSERM UMR 1027, Université Paul Sabatier - Toulouse III, France; Gérontopôle, Centre Hospitalier Universitaire de Toulouse, France.

Marco Canevelli et al. Eur J Intern Med. 2016 Nov.

. 2016 Nov:35:e29-e30.

doi: 10.1016/j.ejim.2016.07.009. Epub 2016 Jul 25.

¹ Department of Neurology and Psychiatry, "Sapienza" University of Rome, Italy. Electronic address: marco.canevelli@gmail.com.
² Department of Neurology and Psychiatry, "Sapienza" University of Rome, Italy.
³ Epidemiology Center, National Institute of Health, Rome, Italy.
⁴ INSERM UMR 1027, Université Paul Sabatier - Toulouse III, France; Gérontopôle, Centre Hospitalier Universitaire de Toulouse, France.

No abstract available

Keywords: Alzheimer's disease; Evidence-based medicine; External validity; Randomized controlled trials.

Publication types